2-(Benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine

Catalog No. :
ACPKIA295
CAS No. :
205672-18-0
Molecular Formula :
C13H14BrN3O
Molecular Weight :
308.18

IUPAC Name:2-(benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine

2-(Benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$137.00Login to see priceInquiryInquiry
250mg98%$254.00Login to see priceInquiryInquiry
1g98%$449.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine
IUPAC Name2-(benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine
MDL No.MFCD18434478
Molecular FormulaC13H14BrN3O
Molecular Weight308.18
SMILESCN(C)C1=C(Br)C=NC(OCC2=CC=CC=C2)=N1
InChI KeyXJFSSPYYQITUEP-UHFFFAOYSA-N
Synonym205672-18-0 | 2-(Benzyloxy)-5-bromo-N,N-dimethylpyrimidin-4-amine | 2-BENZYLOXY-5-BROMO-4-(N,N-DIMETHYLAMINO)PYRIMIDINE | 5-bromo-N,N-dimethyl-2-phenylmethoxypyrimidin-4-amine | C13H14BrN3O | DTXSID10444158 | MFCD18434478 | AKOS015892587 | SB58117 | BS-21897 | CS-0449717 | 4-P
CAS No.205672-18-0
PubChem CID10733573

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H317-H319
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACPKIA295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPKIA295 route product structure diagram
    ACPKIA295205672-18-0
Inquiry

2. ACPKIA295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPKIA295 route product structure diagram
    ACPKIA295205672-18-0
Inquiry

Comments (0)